Cargando…
Trabeculated Myocardium in Hypertrophic Cardiomyopathy: Clinical Consequences
Aims: Hypertrophic cardiomyopathy (HCM) is often accompanied by increased trabeculated myocardium (TM)—which clinical relevance is unknown. We aim to measure the left ventricular (LV) mass and proportion of trabeculation in an HCM population and to analyze its clinical implication. Methods and Resul...
Autores principales: | Casanova, José David, Carrillo, Josefa González, Jiménez, Jesús Martín, Muñoz, Javier Cuenca, Esparza, Carmen Muñoz, Alvárez, Marcos Siguero, Escribá, Rubén, Milla, Esther Burillo, de la Pompa, José Luis, Raya, Ángel, Gimeno, Juan Ramón, Molina, María Sabater, García, Gregorio Bernabé |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600439/ https://www.ncbi.nlm.nih.gov/pubmed/33007916 http://dx.doi.org/10.3390/jcm9103171 |
Ejemplares similares
-
Towards an Enhanced Tool for Quantifying the Degree of LV Hyper-Trabeculation
por: Bernabé, Gregorio, et al.
Publicado: (2021) -
Trabeculated (non-compacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis
por: Kawel, Nadine, et al.
Publicado: (2012) -
Current therapies for hypertrophic cardiomyopathy: a systematic review and meta‐analysis of the literature
por: Bayonas‐Ruiz, Adrián, et al.
Publicado: (2022) -
Genetic Factors Involved in Cardiomyopathies and in Cancer
por: Sabater-Molina, María, et al.
Publicado: (2020) -
Alcohol septal ablation in hypertrophic cardiomyopathy
por: Mateo, Juan José Santos, et al.
Publicado: (2018)